Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cells

Journal of Urology

Volumn 171, Issue 6 I, 2004, Pages 2471-2476

  Fuessel, Susanne ^a   Kueppers, Bernd ^a   Ning, Shuangli ^a   Kotzsch, Matthias ^a   Kraemer, Kai ^a   Schmidt, Uta ^a   Meye, Axel ^a   Wirtht, Manfred P ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Bladder; Bladder neoplasms; Oligonucleotides, antisense; Survivin

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGODEOXYNUCLEOTIDE SVV261; ANTISENSE OLIGODEOXYNUCLEOTIDE SVV264; ANTISENSE OLIGODEOXYNUCLEOTIDE SVV286; MESSENGER RNA; NUCLEIC ACID; RIBOZYME; SMALL INTERFERING RNA; SURVIVIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; EVALUATION; GENE CONSTRUCT; GENE CONTROL; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SECONDARY STRUCTURE; RNA STRUCTURE;

EID: 2442509137     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000116410.13874.b8     Document Type: Article

References (21)

1. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E. and Thun, M. J.: Cancer statistics, 2003. CA Cancer J Clin, 53: 5, 2003
2. Lamm, D. L., Riggs, D. R., Traynelis, C. L. and Nseyo, U. O.: Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder. J Urol, 153: 1444, 1995
3. Duggan, B. J., Gray, S., Johnston S. R., Williamson, K., Miyaki, H. and Gleave, M.: The role of antisense oligonucleotides in the treatment of bladder cancer. Urol Res, 30: 137, 2002
4. Kausch, I. and Bohle, A.: Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer. Eur Urol, 41: 15, 2002
5. Altieri, D. C.: Survivin and apoptosis control. Adv Cancer Res, 88: 31, 2003
6. Swana, H. S., Grossman, D., Anthony, J. N., Weiss, R. M. and Altieri, D. C.: Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med, 341: 452, 1999
7. Gazzaniga, P., Gradilone, A., Giuliani, L., Gandini, O., Silvestri, I., Nofroni, I. et al: Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol, 14: 85, 2003
8. Smith, S. D., Wheeler, M. A., Plescia, J., Colberg, J. W., Weiss, R. M. and Altieri, D. C.: Urine detection of survivin and diagnosis of bladder cancer. JAMA, 285: 324, 2001
9. Altieri, D. C.: The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med, 7: 542, 2001
10. Chen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Cowsert, L. M. et al: Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia, 2: 235, 2000
11. Olie, R. A., Simoes-Wust, A. P., Baumann, B., Leech, S. H., Fabbro, D., Stahel, R. A. et al: A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res, 60: 2805, 2000
12. Xia, C., Xu, Z., Yuan, X., Uematsu, K., You, L., Li, K. et al: Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. Mol Cancer Ther, 1: 687, 2002
13. Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S. et al: Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol, 1: 461, 1999
14. Zuker, M.: Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res, 31: 3406, 2003
15. Kraemer, K., Fuessel, S., Schmidt, U., Kotzsch, M., Schwenzer, B., Wirth, M. P. et al: Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res, 9: 3794, 2003
16. Kappler, M., Kohler, T., Kampf, C., Diestelkotter, P., Wurl, P., Schmitz, M. et al: Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer, 95: 360, 2001
17. Kappler, M., Kotzsch, M., Bartel, F., Fussel, S., Lautenschlager, C., Schmidt, U. et al: Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin Cancer Res, 9: 1098, 2003
18. Branch, A. D.: A good antisense molecule is hard to find. Trends Biochem Sci, 23: 45, 1998
19. Zaffaroni, N. and Daidone, M. G.: Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions. Drug Resist Updat, 5: 65, 2002
20. Choi, K. S., Lee, T. H. and Jung, M. H.: Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of anti-apoptotic function of survivin in MCF-7 cells. Cancer Gene Ther, 10: 87, 2003
21. Williams, N. S., Gaynor, R. B., Scoggin, S., Verma, U., Gokaslan, T. et al: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res, 9: 931, 2003